How I manage Evans Syndrome and AIHA cases in children
Author:
- 2 December 2015
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 172 (4) , 524-534
Abstract
Summary: The management of Evans Syndrome in children is challenging due to the lack of evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in about 80% of cases. For children who are resistant, relapse or become steroid‐dependent, rituximab is considered a valid second‐line treatment, with the exception of those with an underlying diagnosis of autoimmune lymphoproliferative syndrome who may benefit from other options such as mycophenolate mofetil and sirolimus. Better knowledge of the immunological mechanisms underlying cytopenias and the availability of new immunosuppressive drugs can be helpful in the choice of more targeted therapies that would enable the reduction of the use of long‐term steroid administration or other more aggressive options, such as splenectomy or stem cell transplantation. This manuscript provides an overview of the pathogenic background of the disease, and suggests a clinical approach to diagnosis and treatment with a particular focus on the management of relapsing/resistant disease.Keywords
This publication has 98 references indexed in Scilit:
- New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal LeukoencephalopathyJournal of Immunology Research, 2013
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaBlood, 2012
- How I treat autoimmune lymphoproliferative syndromeBlood, 2011
- New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 childrenHaematologica, 2011
- Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopBlood, 2010
- Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)British Journal of Haematology, 2009
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectBlood, 2009
- Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case reportJournal of Medical Case Reports, 2009
- High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome)The Journal of Pediatrics, 1985
- Evans syndrome in childhoodThe Journal of Pediatrics, 1980